From: Hyperoxemia as a risk factor for ventilator-associated pneumonia
Variables | P | OR (95 % CI) |
---|---|---|
Model 1 | ||
SAPS II | 0.019 | 1.01 (1.00, 1.02)* |
Red blood cell transfusion | 0.009 | 1.75 (1.14, 2.70) |
Proton pump inhibitor use | 0.040 | 1.86 (1.03, 3.39) |
Number of days with hyperoxemia | 0.001 | 1.10 (1.04, 1.16)** |
Model 2 | ||
SAPS II | 0.017 | 1.01 (1.00, 1.02)* |
Red blood cell transfusion | 0.009 | 1.79 (1.16, 2.78) |
Proton pump inhibitor use | 0.031 | 1.92 (1.06, 3.50) |
MV duration prior to VAP | 0.012 | 1.10 (1.01, 1.04)** |
Hyperoxemia at ICU admission | 0.004 | 1.89 (1.23, 2.89) |
Model 3 | ||
Red blood cell transfusion | 0.018 | 1.71 (1.10, 2.65) |
Proton pump inhibitor use | 0.017 | 2.10 (1.14, 3.79) |
MV duration prior to VAP | 0.005 | 1.03 (1.01, 1.04)* |
Percentage of days with hyperoxemia | 0.029 | 2.20 (1.08, 4.48)** |